The presence of excess glucose in blood is regarded as a sweet hurt for patients with
diabetes. Human serum albumin (HSA) is the most abundant protein in human plasma …

Objectives: To review the various hemoglobin (Hb) A1c methods, with a focus on
interferences resulting from Hb variants. Methods: HbA1c is a marker used for the diagnosis …

In vivo modification of proteins by molecules with reactive carbonyl groups leads to
intermediate and advanced glycation end products (AGE). Glucose is a significant glycation …

Type 2 diabetes mellitus (DM), which is epidemic in low-and middle-income countries
(LMICs), may threaten gains made in tuberculosis (TB) control, as DM is both a major risk …

Time to question the NHS diabetes prevention programme | The BMJ Skip to main content
Intended for healthcare professionals Access provided by Google Indexer Subscribe My …

Context.—It is recommended that hemoglobin (Hb) A1c (Hb A1c) not be used to assess
average glycemia in patients who have altered red blood cell life span. Objective.—To …

Background Hemoglobinopathies are mutations resulting in abnormal globin chain
structure; some have clinically significant outcomes such as anemia or reduced lifespan …

Noncommunicable diseases (NCDs), including cardiovascular diseases and diabetes, have
emerged as an underappreciated health threat with enormous economic and public health …

Objectives Although clinicians do not routinely screen for diabetic retinopathy in non-
diabetic patients, previous studies have shown that diabetic retinopathy can occur in …

Background HbA1c is used in the diagnosis and monitoring of diabetes mellitus (DM).
Interference from hemoglobin variants is a well-described phenomenon, particularly with …